文献速递冠心病血脂与心血管预防

年轻心梗患者心血管风险与汀类 eligibility:YOUNG-MI 注册研究

Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.
PubMed 文献 · J Am Coll Cardiol · 2017-11-12

YOUNG-MI 注册研究回顾性纳入 1,475 例首次心梗年龄≤50 岁患者,评估其心梗前是否符合 2013 ACC/AHA 指南和 2016 USPSTF 汀类一级预防标准。仅 49% 和 29% 分别符合两标准,女性不符合比例更高(63% vs 46%,p<0.001),提示年轻心梗患者多数不符合现行汀类治疗阈值。

要点

  • 年轻心梗患者中仅 49% 符合 2013 ACC/AHA 汀类标准,29% 符合 2016 USPSTF 标准。
  • 女性不符合汀类标准的比例显著高于男性(63% vs 46%,p<0.001)。
  • 多数年轻心梗患者心梗前不符合现行汀类一级预防阈值,需更好的风险评估工具。

核心结论

  • 绝大多数年轻心梗患者在心梗前不符合现行指南汀类治疗阈值,女性尤为明显。

研究设计与样本

  • YOUNG-MI 注册研究为来自 2 个大型学术中心的回顾性队列,纳入首次心梗年龄≤50 岁患者,1 型心梗由研究医生裁定。

主要发现

  • 1,475 例未用汀类患者中,中位年龄 45 岁,女性 294 例(20%),STEMI 846 例(57%),至少 1 个心血管危险因素者 1,225 例(83%)。
  • 队列中位 10 年 ASCVD 风险评分为 4.8%(IQR 2.8%–8.0%)。
  • 仅 724 例(49%)符合 2013 ACC/AHA 汀类标准,430 例(29%)符合 2016 USPSTF 标准。
  • 女性中 184 例(63%)不符合任一指南汀类标准,男性中 549 例(46%)不符合(p<0.001)。

关键数值与推荐

  • 2013 ACC/AHA 指南汀类 eligibility 标准:符合者 724 例(49%)。
  • 2016 USPSTF 汀类一级预防推荐标准:符合者 430 例(29%)。
  • 女性不符合任一指南标准比例 63%,男性 46%(p<0.001)。

临床怎么用

  • 对年轻成人(尤其女性)应加强风险评估,不应仅依赖现行指南阈值决定汀类启动。

局限性

  • 回顾性队列设计,来自 2 个学术中心,可能存在选择偏倚。
  • 风险评分基于心梗前或就诊时数据,部分数据可能不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite significant progress in primary prevention, the rate of MI has not declined in young adults. OBJECTIVES: The purpose of this study was to evaluate statin eligibility based on the 2013 American College of Cardiology/American Heart Association guidelines for treatment of blood cholesterol and 2016 U.S. Preventive Services Task Force recommendations for statin use in primary prevention in a cohort of adults who experienced a first-time myocardial infarction (MI) at a young age. METHODS: The YOUNG-MI registry is a retrospective cohort from 2 large academic centers, which includes patients who experienced an MI at age ≤50 years. Diagnosis of type 1 MI was adjudicated by study physicians. Pooled cohort risk equations were used to estimate atherosclerotic cardiovascular disease risk score based on data available prior to MI or at the time of presentation. RESULTS: Of 1,685 patients meeting inclusion criteria, 210 (12.5%) were on statin therapy prior to MI and were excluded. Among the remaining 1,475 individuals, the median age was 45 years, there were 294 (20%) women, and 846 (57%) had ST-segment elevation MI. At least 1 cardiovascular risk factor was present in 1,225 (83%) patients. The median 10-year atherosclerotic cardiovascular disease risk score of the cohort was 4.8% (interquartile range: 2.8% to 8.0%). Only 724 (49%) and 430 (29%) would have met criteria for statin eligibility per the 2013 American College of Cardiology/American Heart Association guidelines and 2016 U.S. Preventive Services Task Force recommendations, respectively. This finding was even more pronounced in women, in whom 184 (63%) were not eligible for statins by either guideline, compared with 549 (46%) men (p < 0.001). CONCLUSIONS: The vast majority of adults who present with an MI at a young age would not have met current guideline-based treatment thresholds for statin therapy prior to their MI. These findings highlight the need for better risk assessment tools among young adults.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Singh A, Collins BL, Gupta A, et al. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol. 2017. PMID: 29141201. doi:10.1016/j.jacc.2017.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。